Details for New Drug Application (NDA): 210546
✉ Email this page to a colleague
The generic ingredient in CLOBAZAM is clobazam. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the clobazam profile page.
Summary for 210546
Tradename: | CLOBAZAM |
Applicant: | Lupin Ltd |
Ingredient: | clobazam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 2.5MG/ML | ||||
Approval Date: | Dec 28, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription